4//SEC Filing
Azamian Bobak R. 4
Accession 0001827672-23-000050
CIK 0001819790other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:08 PM ET
Size
6.3 KB
Accession
0001827672-23-000050
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Sale
Common Stock
2023-12-27$20.22/sh−8,000$161,760→ 830,106 total(indirect: By Trust)
Holdings
- 8,597
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.00 to $20.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827672
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:08 PM ET
- Size
- 6.3 KB